The HEPHAISTOS Trial and Mammalian Target of Rapamycin Inhibitors in Liver Transplantation-Hiding in Plain Sight

Liver Transpl. 2022 Jun;28(6):925-927. doi: 10.1002/lt.26424. Epub 2022 Mar 3.

Author

Greg J McKenna¹

Affiliation

¹ Simmons Transplant Institute, Baylor University Medical Center Dallas TX Texas A&M University School of Medicine Dallas TX.

PMID: 35124886
DOI: 10.1002/lt.26424

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Liver Transplantation* / adverse effects
Sirolimus* / adverse effects
TOR Serine-Threonine Kinases

Substances

TOR Serine-Threonine Kinases
Sirolimus